|
|
Latest Headlines
Xcelience and IriSys business alliance agreement strengthens regional access to CMC/Regulatory expertise
 More...
| Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area
More...
| Xcelience and Penn Pharma Form a Joint Venture to Provide API Into Capsule Services in Europe and Asia Pacific Markets
More...
|
|
|
|
|
|
|
News
|
|
|
|
Xcelience’s Scientific Director selected to lead key sessions on upcoming conferences
|
|
Dr. Steve Bannister’s expertise requested for several speaking engagements over the next year
|
|
Tampa, FL October 25, 2007 – Dr. Steve J. Bannister, Scientific Director and Principal Consultant for leading Tampa-based CRO Xcelience, will be moderating the “Innovation and Success Strategies – Learning and Un-learning from Key Players” panel at the New Directions for Drug Delivery Conference on October 29 in Las Vegas, Nevada.
|
|
Dr. Bannister will be conducting a panel of key industry leaders from prolific companies LifeTech Innovations, MicroCHIPS, Durect and McDonnel Boehnen Hulbert & Berghoff, who will be sharing their insights on innovations and growth in today’s drug delivery business.
|
|
Steve Bannister, a much sought after expert with over two decades of experience in pharmaceutical development, will also be the chairperson for “Challenging the Science – Lighting the Path”, the opening session of the 2008 Global Cancer Conference in Tampa on January 28, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|